Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Histatin 3 is a non-standardized allergenic extract used in clinical immunology for the diagnosis and management of specific hypersensitivity reactions. It belongs to the class of Non-Standardized Food and Plant Allergenic Extracts.
Name
Histatin 3
Raw Name
HISTATIN 3
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
3
Variant Count
3
Last Verified
February 17, 2026
About Histatin 3
Histatin 3 is a non-standardized allergenic extract used in clinical immunology for the diagnosis and management of specific hypersensitivity reactions. It belongs to the class of Non-Standardized Food and Plant Allergenic Extracts.
Detailed information about Histatin 3
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Histatin 3.
As a non-standardized extract, Histatin 3 does not have a universally defined potency unit (like the Bioequivalent Allergy Units or BAU used for standardized extracts like grass pollen or dust mites). Instead, its strength is typically expressed in terms of weight-to-volume (w/v) ratios or Protein Nitrogen Units (PNU). This classification means that while the extract is manufactured under strict Current Good Manufacturing Practices (cGMP), the specific biological activity may vary between lots, requiring healthcare providers to exercise precise clinical judgment during administration. Histatin 3 belongs to a broader class of diagnostic agents used by allergists and immunologists to identify the specific triggers of Type I hypersensitivity reactions (IgE-mediated allergies).
The mechanism of action for Histatin 3 depends entirely on its application: diagnostic or therapeutic. At the molecular level, Histatin 3 acts as an allergen. When introduced into the skin of a sensitized individual during a skin prick test, the Histatin 3 protein molecules cross-link specific Immunoglobulin E (IgE) antibodies that are bound to the surface of mast cells and basophils. This cross-linking triggers a process called degranulation, where the cells release inflammatory mediators, most notably histamine, leukotrienes, and prostaglandins. This localized chemical release results in the 'wheal and flare' reaction—a raised bump and surrounding redness—which serves as a visual confirmation of the patient's sensitivity to that specific protein.
In the context of immunotherapy (allergy shots), the mechanism shifts toward immunomodulation. By exposing the patient to gradually increasing doses of the Histatin 3 extract over several months, the immune system undergoes a 'class switch.' The body begins to produce IgG4 antibodies (blocking antibodies) instead of IgE. Furthermore, the treatment promotes the development of regulatory T-cells (Tregs) that suppress the allergic inflammatory response. Over time, this reduces the patient's clinical symptoms upon natural exposure to the allergen.
Because Histatin 3 is a biological protein extract administered either epicutaneously (on the skin) or subcutaneously (under the skin), its pharmacokinetic profile differs significantly from traditional oral medications.
Histatin 3 extracts are primarily used for:
Histatin 3 is typically available in the following formats:
> Important: Only your healthcare provider can determine if Histatin 3 is right for your specific condition. The selection of specific extracts must be based on a thorough clinical history and physical examination.
Dosage for Histatin 3 is highly individualized and must be determined by an allergy specialist. Unlike standard medications, there is no 'one-size-fits-all' dose.
For skin prick testing, a single drop of the extract (typically at a concentration of 1:20 w/v or as specified by the manufacturer) is applied to the forearm or back. A sterile lancet is then used to prick the skin through the drop. Results are read exactly 15 to 20 minutes later.
If used for immunotherapy, the 'Build-up Phase' usually begins with a very dilute solution (e.g., 1:100,000 or 1:10,000 v/v). Injections are given 1–2 times per week, with the dose increasing by 20–50% each time, provided the patient tolerates the previous dose without a significant local or systemic reaction. The 'Maintenance Phase' is reached when the patient can tolerate a high-concentration dose (the maintenance dose), which is then administered every 2–4 weeks for a period of 3 to 5 years.
Histatin 3 extracts may be used in children, but the procedure requires extreme caution. The dosage concentrations for skin testing are generally the same as adults, but the number of tests performed in a single session may be limited to prevent excessive discomfort or systemic absorption. In immunotherapy, pediatric doses are calculated based on the same titration principles as adults, though the starting dose may be more conservative in highly sensitive children. Safety and efficacy for immunotherapy in children under the age of 5 have not been extensively established, and the decision to proceed must involve a careful risk-benefit analysis by a pediatric allergist.
No specific dosage adjustments are required for patients with renal impairment, as the systemic protein load is minimal. However, patients with severe renal disease may have altered skin reactivity, potentially leading to false-negative diagnostic results.
No dosage adjustments are established for hepatic impairment. The metabolic clearance of small amounts of injected protein is not expected to be significantly affected by liver dysfunction.
Elderly patients (over 65) should be evaluated for underlying cardiovascular disease before undergoing testing or immunotherapy. If a systemic reaction occurs, the use of epinephrine may pose a higher risk in patients with pre-existing heart conditions. Furthermore, skin reactivity decreases with age, which may require the use of positive controls (histamine) to validate test results.
Histatin 3 is never self-administered by the patient at home. It must be administered in a clinical setting equipped to handle anaphylaxis.
In immunotherapy, consistency is critical. If a dose is missed:
An 'overdose' in the context of Histatin 3 refers to the administration of a concentration higher than the patient's current tolerance level. Signs include massive local swelling at the injection site, generalized hives (urticaria), swelling of the throat (angioedema), wheezing, or a drop in blood pressure. Emergency treatment with epinephrine, antihistamines, and fluids is required immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to self-administer these extracts without medical guidance.
The most frequent side effects associated with Histatin 3 are localized to the site of administration.
> Warning: Stop the administration process and call your doctor or emergency services immediately if you experience any of the following symptoms of anaphylaxis:
There are no known long-term 'toxic' effects of Histatin 3, as it is a biological protein. However, the primary long-term risk is the development of increased sensitivity if the immunotherapy is not managed correctly. In rare cases, subcutaneous nodules (small, hard lumps under the skin) may form at the site of repeated injections; these are usually benign but should be monitored by a physician.
While Histatin 3 itself may not have a specific individual black box warning, the entire class of Allergenic Extracts carries a standard FDA-mandated warning regarding Anaphylaxis.
Summary of Warning:
Report any unusual symptoms or delayed reactions (occurring hours after the appointment) to your healthcare provider immediately.
Histatin 3 must be used with extreme caution. Because it is a non-standardized extract, the biological potency can vary between different manufacturers and even between different lots from the same manufacturer. Patients switching from one lot to another may require a dose reduction to ensure safety. This product is intended for use only by healthcare professionals trained in allergy and immunology.
No specific FDA black box warning exists solely for Histatin 3; however, it falls under the mandatory class warning for all allergenic extracts. This warning emphasizes that these products can cause anaphylaxis, which can be fatal. It mandates that emergency equipment, including oxygen, IV fluids, and epinephrine, must be immediately available during administration.
Histatin 3 generally does not affect the ability to drive or operate machinery. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive until cleared by a medical professional. Some patients may feel mild fatigue after an injection and should use caution until they know how the treatment affects them.
Alcohol consumption should be avoided for several hours before and after receiving Histatin 3. Alcohol can increase blood flow to the skin and potentially accelerate the absorption of the allergen, increasing the risk of a systemic reaction. It can also mask the early symptoms of an allergic response.
If immunotherapy is discontinued, there is no 'withdrawal syndrome.' However, the patient's allergy symptoms will likely return to their baseline over time. If treatment is stopped for more than a few weeks and then restarted, the dose must be significantly reduced to avoid a reaction.
> Important: Discuss all your medical conditions, especially any history of heart problems or asthma, with your healthcare provider before starting Histatin 3.
There are no direct chemical interactions between Histatin 3 and specific foods. However, patients should avoid eating a large, heavy meal immediately before an injection, as this can complicate the management of gastrointestinal symptoms if a systemic reaction occurs. If Histatin 3 is being used to test for a food allergy, the patient should avoid that specific food to prevent 'summation' of the allergic trigger.
Histatin 3 does not typically interfere with standard blood chemistry or hematology labs. However, it will directly affect:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any heart or blood pressure medications.
Histatin 3 must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients allergic to Histatin 3 may show cross-reactivity with other proteins in the Histatin family or other histidine-rich proteins found in certain plant species. If a patient is known to be extremely sensitive to one member of the 'Non-Standardized Plant Allergenic Extract' class, they should be approached with extreme caution when testing with Histatin 3.
> Important: Your healthcare provider will evaluate your complete medical history, including your current lung function and heart health, before prescribing Histatin 3.
Histatin 3 is classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and it is not known whether the extract can cause fetal harm. The primary concern during pregnancy is not the protein itself (which does not cross the placenta in harmful amounts) but the risk of maternal anaphylaxis. If the mother experiences a severe drop in blood pressure or respiratory failure, the fetus may suffer from hypoxia (oxygen deprivation), which can lead to miscarriage or neurological damage.
Clinical Consensus: Healthcare providers typically do not start new immunotherapy or perform extensive skin testing during pregnancy. If a woman is already on a stable maintenance dose of Histatin 3 and is tolerating it well, the treatment may be continued, but the dose is often not increased during the pregnancy.
It is not known if Histatin 3 components are excreted in human milk. However, because these are large proteins and the amount administered is very small, it is highly unlikely that they would be absorbed intact by the nursing infant's gut. Breastfeeding is generally considered safe during Histatin 3 administration, provided the mother is monitored for systemic reactions.
Histatin 3 is used in the pediatric population for both diagnosis and treatment. However, clinicians must be aware that children may have difficulty describing the early 'aura' of an allergic reaction (such as an itchy throat or a sense of impending doom). Special care must be taken to monitor objective signs like coughing, hives, or changes in activity level. Immunotherapy is rarely started in children under age 5 due to cooperation issues and the risk profile.
In patients over 65, the 'wheal and flare' response during diagnostic testing may be diminished due to age-related changes in skin physiology. This can lead to false negatives. Furthermore, the risk of cardiovascular complications from a systemic reaction is higher in this age group. A thorough cardiac evaluation is recommended before starting an elderly patient on a long-term immunotherapy program.
No dosage adjustments are formally established for patients with kidney disease. However, uremia (buildup of toxins in the blood due to kidney failure) can suppress skin reactivity, potentially making diagnostic tests less reliable.
Liver disease does not significantly impact the processing of Histatin 3 extracts. However, patients with severe hepatic failure may have coagulopathies (bleeding disorders) that could increase the risk of bruising at the injection site.
> Important: Special populations require individualized medical assessment and often a more conservative approach to dosing.
Histatin 3 is a protein-based allergen. Its primary pharmacological action is the induction of Type I Hypersensitivity. Upon exposure, the protein binds to IgE antibodies on the surface of mast cells. This triggers the activation of the high-affinity IgE receptor (FcεRI), leading to an influx of calcium ions and the subsequent release of pre-formed mediators like histamine. In immunotherapy, Histatin 3 works by inducing immunological tolerance. This involves the shift from a Th2-dominated immune response (which produces IgE) to a Th1/Treg-dominated response (which produces IgG4 and IL-10), effectively 'desensitizing' the patient.
| Parameter | Value |
|---|---|
| Bioavailability | Low (localized to skin/subcutaneous tissue) |
| Protein Binding | N/A (Processed by immune cells) |
| Half-life | Minutes to hours (Proteolysis) |
| Tmax | 15-20 mins (Skin test); 1-2 hours (Systemic absorption) |
| Metabolism | Cellular Proteases |
| Excretion | Renal (as amino acids/peptides) |
Histatin 3 is classified as an Allergenic Extract. It belongs to the Estabished Pharmacologic Classes (EPC) of Non-Standardized Food Allergenic Extract and Non-Standardized Plant Allergenic Extract. It is related to other diagnostic allergens like Timothy Grass Extract or Ragweed Extract, though those are often 'Standardized.'
Common questions about Histatin 3
Histatin 3 is primarily used as a diagnostic tool to identify specific allergies and as a therapeutic agent in allergen immunotherapy. In diagnostic settings, it is applied during a skin prick test to see if a patient develops a 'wheal and flare' reaction, indicating a sensitivity to that protein. For therapy, it is used in 'allergy shots' to help the body build up a tolerance to the allergen over time. This can significantly reduce symptoms of allergic rhinitis, asthma, or other allergic conditions. It is always administered by a specialist, such as an allergist or immunologist.
The most common side effects are localized to the area where the extract was applied or injected. During a skin test, this typically involves an itchy, red bump that appears within 20 minutes and fades within an hour. For those receiving immunotherapy injections, common side effects include redness, swelling, and itching at the injection site that may last for a day or two. Some patients may also experience mild 'hay fever' symptoms or slight fatigue. While these are usually not dangerous, any large swelling should be reported to your doctor. Serious systemic reactions are rare but require immediate medical attention.
It is generally advised to avoid alcohol on the days you receive Histatin 3 injections or undergo skin testing. Alcohol can cause vasodilation (widening of the blood vessels), which might increase the rate at which the allergen is absorbed into your bloodstream. This can potentially increase the risk of a systemic allergic reaction or anaphylaxis. Furthermore, alcohol can mask early symptoms of an allergic reaction, such as feeling flushed or dizzy, making it harder to identify an emergency. Always follow the specific 'pre-injection' instructions provided by your allergy clinic regarding diet and lifestyle.
Histatin 3 is generally not started as a new treatment during pregnancy because of the risk of anaphylaxis. If a mother has a severe allergic reaction, it can cause a dangerous drop in blood pressure that reduces oxygen flow to the baby. However, if a woman is already on a stable maintenance dose of immunotherapy and is tolerating it well, many allergists will continue the treatment at that same dose. Skin testing is also usually postponed until after delivery. If you are planning to become pregnant or find out you are pregnant while on Histatin 3, you must notify your allergist immediately to adjust your treatment plan.
As a diagnostic test, Histatin 3 works almost immediately, providing results within 15 to 20 minutes of application. However, as a treatment (immunotherapy), it is a slow process that requires patience. Most patients begin to feel a reduction in their allergy symptoms during the 'maintenance phase,' which usually occurs 6 to 12 months after starting the injections. The full benefit of the treatment is often not reached until the patient has been on the shots for 2 to 3 years. Most experts recommend continuing the treatment for 3 to 5 years to ensure long-lasting immunity after the shots are stopped.
Yes, you can stop Histatin 3 immunotherapy suddenly without experiencing physical withdrawal symptoms like you might with certain other medications. However, stopping the treatment before the recommended 3-to-5-year course is finished usually means your allergy symptoms will eventually return. If you miss several doses and then try to restart, you cannot simply take your last dose; your doctor will need to significantly reduce the concentration to prevent a reaction. If you are considering stopping your allergy shots, discuss your reasons with your allergist to see if a schedule adjustment might be a better option.
If you miss an appointment for your Histatin 3 immunotherapy, contact your allergist's office as soon as possible to reschedule. Do not try to 'make up' the dose by taking more later. The safety of immunotherapy depends on a very specific timing and dosage increase. If you miss only one week, your doctor may give you your usual dose. If you miss several weeks, they will likely need to decrease your dose to ensure you don't have a reaction when you restart. Consistency is the most important factor in making the treatment both safe and effective.
There is no clinical evidence to suggest that Histatin 3 allergenic extracts cause weight gain. Unlike systemic corticosteroids (like prednisone), which are known to affect metabolism and appetite, Histatin 3 is a protein extract that works specifically on the immune system. It does not contain hormones or calories that would lead to weight changes. If you experience weight gain while on immunotherapy, it is likely due to other factors or medications, such as antihistamines that might increase appetite in some individuals. You should discuss any unexpected weight changes with your primary care physician.
Histatin 3 can be taken with many medications, but there are critical exceptions. You must tell your doctor if you are taking beta-blockers, as these can make allergic reactions much more dangerous and difficult to treat. Antihistamines must be stopped several days before diagnostic skin testing, as they will block the results. However, most other routine medications for blood pressure (except ACE inhibitors in some cases), cholesterol, or diabetes do not interfere with Histatin 3. Always provide your allergist with a complete and updated list of all medications, including over-the-counter supplements.
The concept of 'generic' is slightly different for biological products like allergenic extracts. Histatin 3 is a non-standardized extract, meaning different manufacturers may produce their own versions of the extract. While they may be biologically similar, they are not considered 'interchangeable' in the way a generic ibuprofen tablet is interchangeable with a brand-name one. If your doctor switches you from one manufacturer's extract to another, they will often reduce your dose slightly to account for potential differences in potency. Always ensure your treatment is being managed by a qualified specialist who understands these nuances.